1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C17180893F07B5C385256A2A006B52D5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/multiple-formulations-strategies-maximizing-drug-lifetime-value
18
19
2018.215.159.156
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Brand Management and Product Leadership Lifecycle Management

Multiple Formulations Strategies: Maximizing Drug Lifetime Value

DB Image

ID: 4061


Features:

Graphics


Words: 6,509


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
An emerging lifecycle management issue centers around drug formulations. Companies increasingly recognize the value of using multiple formulations to penetrate markets faster, create higher barriers to entry, and maximize the economic potential of their products. Nevertheless, companies have yet to develop more consistent criteria and processes to help them make effective formulation development decisions. Building upon Best Practices, LLC’s extensive research on global pharmaceutical launches and lifecycle management, this benchmarking review focuses on current and emerging drug formulations strategies and practices that top pharmaceutical companies use to increase their products’ commercial success.

Industries Profiled:
Pharmaceutical; Biotech; Health Care; Manufacturing


Companies Profiled:
Pfizer; Sanofi-aventis; Glaxo-Wellcome; Schering-Plough; Alza Corporation; Merck; Pharmacia; SmithKline Beecham; Novartis; Alliance Pharmaceuticals


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.